Annika Maria Olsson

Director at GasPorOx AB

Annika Maria Olsson

Annika Maria Olsson

Director at GasPorOx AB

Biography

Annika Maria Olsson is on the board of Gasporox AB, PackBridge AB and Lunicore AB and Professor at the University of Lund.

Overview
RelSci Relationships

159

Number of Boards

4

Birthday

1962

Age

59

Relationships
RelSci Relationships are individuals Annika Maria Olsson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President of Business Area, Nordic at ÅR Packaging Holding AB

Relationship likelihood: Strong

Chief Executive Officer at LU Holding AB

Relationship likelihood: Strong

Chief Operating Officer at LU Holding AB

Relationship likelihood: Strong

Director of Innovations & Chief Executive Officer at LU Holding AB

Relationship likelihood: Strong

Chief Executive Officer at GasPorOx AB

Relationship likelihood: Strong

Co-Founder at EQL Pharma AB

Relationship likelihood: Strong

Director at GasPorOx AB

Relationship likelihood: Strong

Former Independent Director at GasPorOx AB

Relationship likelihood: Strong

Former Managing Director at SINTEF SI

Relationship likelihood: Strong

Dean of the Faculty of Medicine at Lund University

Relationship likelihood: Strong

Paths to Annika Maria Olsson
Potential Connections via
Relationship Science
You
Annika Maria Olsson
Director at GasPorOx AB
Career History
Director
Current

Gasporox AB engages in the provision of laser sensor package solutions. It offers stand-alone instruments; modules for automation; and measurement service. The firm also develops solutions that adapts to specific packages or production processes. It also provides technology for gas monitoring in food and pharmaceutical packages, as well as porous materials and food. The company was founded by Katarina Svanberg, Märta Lewander Xu, and Sune Roland Svanberg in April 2005 and is headquartered in Lund, Sweden.

Professor
Current

The University is ranked as one of the top 100 in the world. They tackle complex problems and global challenges and work to ensure that knowledge and innovations benefit society. They provide education and research in engineering, science, law, social sciences, economics and management, medicine, humanities, theology, fine art, music and drama. Their 47 700 students and 7 500 employees are based at their campuses in Lund, Malm and Helsingborg. The University has a turnover of around SEK 7 475 million (EUR 844 million), of which two thirds is in research and one third in education. They are an international university with global recruitment. They cooperate with 680 partner universities in over 50 countries and are the only Swedish university to be a member of the strong international networks LERU (the League of European Research Universities) and Universitas 21. Two major facilities for materials research are currently under construction in Lund: the MAX IV Laboratory, which will be a world-leading synchrotron radiation laboratory and ESS, a European facility that will be home to the world's most powerful neutron source. These will be of decisive importance for materials and life sciences and for industrial development. In Lund, Medicon Village has also been established and will offer a unique environment for life sciences; integrating research, innovation and enterprise creates the conditions for improved health and quality of life.

Boards & Committees
Board Member
Current

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

Other Affiliations

Annika Maria Olsson is affiliated with GasPorOx AB, Lund University, LU Holding AB

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Annika Maria Olsson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Annika Maria Olsson's profile does not indicate a business or promotional relationship of any kind between RelSci and Annika Maria Olsson.